摘要
目的:分析接受靶向治疗肺癌患者的住院费用、费用构成及影响因素。方法:收集样本三甲医院2013年1月至2016年12月收治的接受靶向治疗肺癌患者的住院费用信息,采用描述性分析、多重线性回归方法进行分析。结果:纳入研究的386例患者住院费用的中位值为41 128.80元。费用构成中,占比最高的前三项是西药费、检查费、化验费,分别占49.11%、10.05%、7.52%。住院次数、平均住院日、是否手术、是否输血和性别是影响接受靶向治疗的肺癌患者住院费用的主要因素。结论:接受靶向治疗的肺癌患者面临沉重的医疗负担,建议探寻合理的靶向治疗费用分担机制。接受靶向治疗肺癌患者的住院费用随着住院次数、平均住院日的增加而增加,建议通过加强医院管理,如严把住院指征,规范诊疗方案,加强部门间配合,降低术前等待住院日等,以识别和规避无效住院和无效住院日。
Objective:To analyze the hospitalization expense,expense composition and influencing factors of lung cancer patients receiving targeted therapy.Methods:The hospitalization expense information of lung cancer patients receiving targeted therapy admitted to a tertiary hospital from January 2013 to December 2016 is collected and analyzed by descriptive analysis and multiple linear regressions.Results:The median hospitalization expense of 386 patients included in the study was 41 128.80 yuan.Among the expenses,the top 3 are western medicine expenses,inspection expenses and laboratory expenses,accounting for 49.11%,10.05% and7.52% respectively.Hospitalization frequency,average length of stay,surgery,blood transfusion and gender are the main factors influencing hospitalization expense.Conclusion:Lung cancer patients receiving targeted therapy are faced with heavy medical burden,so it is suggested to explore a reasonable cost-sharing mechanism of targeted therapy.The hospitalization expense of lung cancer patients receiving targeted therapy increases with the increase of hospitalization times and average hospitalization days.It is suggested to identify and avoid invalid hospitalization and invalid hospitalization days by strengthening hospital management,such as being strict with hospitalization indications,standardizing diagnosis scheme,strengthening inter-department cooperation,and reducing preoperative waiting time for hospitalization.
作者
李陈晨
翟运开
蒋帅
张然
李思琪
赵杰
LI Chen-chen;ZHAI Yun-kai;JIANG Shuai(The First Affiliated Hospital of Zhengzhou University,National Engineering Laboratory for Internet Medical Systems and Applications,Zhengzhou,450052,China;不详)
出处
《中国卫生经济》
北大核心
2020年第7期35-37,共3页
Chinese Health Economics
基金
科技部重点研发计划项目(2017YFC0909900)。
关键词
肺癌
精准医疗
靶向治疗
住院费用
影响因素
lung cancer
precision medicine
targeted therapy
hospitalization expense
influencing factor
